Immune Checkpoints and Innovative Therapies in Glioblastoma
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2018.00464
Abstract: Targeting the Immune Checkpoint molecules (ICs; CTLA-4, PD-1, PD-L1/2, and others) which provide inhibitory signals to T cells, dramatically improves survival in hard-to-treat tumors. The establishment of an immunosuppressive environment prevents endogenous immune response in… read more here.
Keywords: checkpoints innovative; therapies glioblastoma; innovative therapies; immune checkpoints ... See more keywords